Anti-glomerular basement membrane (GBM) antibody disease is a rare but well-characterized cause of glomerulonephritis. Patients present with rapidly progressive renal failure with hemoptysis. Early diagnosis is crucial in salvaging the renal damage and life-threatening pulmonary hemorrhage. Plasmapheresis and immunosuppression is the mode of therapy. Anti-GBM antibodies are polyclonal in nature. However, rare monoclonal antibodies can cause similar destruction of glomerular capillary walls. We describe distinct combination of circulating monoclonal and anti-GBM nephritis.
Introduction
Anti-glomerular basement membrane (GBM) glomerulonephritis is a rare autoimmune disease manifesting as rapidly progressive glomerulonephritis (RPGN) and pulmonary hemorrhage. [1] These are nearly always polyclonal IgG with exceptional cases of polyclonal IgA. [1] Unlike other autoimmune diseases that have waxing and waning disease course, untreated anti-GBM nephritis progresses rapidly to end-stage kidney disease in almost all cases. [1] Timely diagnosis and treatment with plasmapheresis and immunosuppressant medications is of paramount importance to salvage the kidney.
Plasma cell dyscrasia (PCD) induced renal damage due to monoclonal immunoglobulins (heavy/light chains) manifests variedly as unexplained anemia/ renal failure and nephrotic illness and reflects histologically either in the form of cast nephropathy, monoclonal immunoglobulin deposit disease (MIDD), or Amyloid light chain/ Amyloid heavy chain-amyloidosis. [2] [3] [4] Herein, we present a case having combination of anti-GBM glomerulonephritis and paraproteinemia in the form of circulating monoclonal IgG1-kappa antibodies.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. Renal histology showed four glomeruli, all of which possessed circumferential active cellular crescents and fibrinoid material deposition [ Figure 1a ]. Capillary tufts were nonproliferative but had disruption of capillary basement membranes and Bowman's capsule. Severe acute tubular injury was noticed. There was no giant cell reaction. A diagnosis of anti-GBM crescentic glomerulonephritis with monoclonality (IgG1-kappa light chain restriction) was made. Further detailed post-biopsy serum investigations are shown in Table 1 .
The patient was treated with intravenous (IV) methyl prednisolone 500 mg, 1 dose of cyclophosphamide 500 mg, and subsequently switched to oral steroids 1 mg/kg/day. Eight sessions of plasmapheresis were performed in addition to regular hemodialysis. Targeted therapy including bortezomib-based regimen was discussed with patient attendants, but they were hesitant due to financial constraints and the patient was lost to follow-up.
Discussion
Crescentic glomerulonephritis is the morphologic counterpart of RPGN. [1] Glomerular histology is characterized by active crescents. [1] IgG staining along capillary walls is pathognomonic of anti-GBM nephritis, which is often polyclonal. A differential diagnosis of heavy/light deposit disease in a crescentic transformation is a remote theoretical possibility if one of the light chains is found to be restricted. Lack of powdery deposits in ultrastructure excludes the latter. [3] Autoantibodies are usually polyclonal in nature, directed against NC1 domain of α3 chain and α5 chain of type IV collagen. [1] Rarely, these antibodies are monoclonal with/without circulating antibodies. Savige et al. have described lambda light chain-mediated anti-GBM disease in a 77-year-old male. [5] Similarly, there are anecdotal case reports of circulating monoclonal IgA-kappa antibodies causing severe renal failure and crescentic glomerulonephritis, monoclonal gammopathy of undetermined significance and Waldenstrom's macroglobulinemia, [6, 7] and recurrence in allograft. [8, 9] Our case is the first report demonstrating circulating IgG1-kappa monoclonal antibodies and anti-GBM crescentic glomerulonephritis with linear staining for monoclonal IgG1-kappa light chain restriction. Smoking, one of the known risk factors associated with autoantibody production, was noticed in this patient.
Coley et al. have recently described a patient with monoclonal IgG1-kappa anti-GBM antibody-related glomerulonephritis without a circulating antibody despite repeat testing by multiplex bead assay. [10] Renal histology was that of diffuse endocapillary and exudative glomerulonephritis without crescents in twenty glomeruli sampled on first instance. Myeloma workup including serum and urine paraprotein, bone marrow biopsy, and serum-free light chain ratio were normal. He was treated with immunosuppressant drugs and had an indolent clinical course. An indicated repeat biopsy 9 years later demonstrated similar histology with solitary fibrocellular crescent and progressive glomerulosclerosis/ tubulointerstitial scarring. In contrast to this, our patient had aggressive presentation, 100% active circumferential crescents at the outset, demonstrable paraprotein in the serum, and altered serum-free light chain assay. Bone marrow in our case is similar to those described in previous cases of monoclonal anti-GBM nephritis. [5] [6] [7] [8] [9] [10] The percentages of plasma cells were within the normal range (<10% plasma cells). In the scenario of focal crescents, it is very important to remember passive adsorption of IgG linear staining as highlighted by Coley et al. [10] We can definitely exclude this possibility in our case by virtue of serum paraprotein and more importantly positive linear pattern for >1 antisera (IgG, IgG1, and kappa).
Spectrum of glomerular lesions associated with PCD includes MIDD, AL/AH amyloidosis, cryoglobulinemic glomerulonephritis, immunotactoid glomerulonephritis, and crystalloid glomerulopathy. [2] [3] [4] However, production of monoclonal anti-GBM antibodies causing destruction of GBMs with crescentic transformation is rarely described. One would argue that our patient had two diseases simultaneously. Kappa light chain restriction in immunofluorescence was useful, and a common link between two diseases postulating causative factor. In summary, we report an aggressive case of circulating monoclonal antibodies causing anti-GBM crescentic glomerulonephritis, adding to the expanding spectrum of glomerular lesions associated with PCD.
